SARMs

ACP-105 5 mg Vital Research

Vital Research

80,00

In Stock (100 available)

ACP-105 5 mg Vital Research (5 mg) — This Vital Research formulation delivers this research-grade peptide compound is designed for targeted physiological enhancement. …

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

ACP-105 5 mg Vital Research — ACP-105 from Vital Research at 5 mg. Non-steroidal SARM with tissue-selective AR agonism — potency between ostarine and ligandrol. Mild-to-moderate HPTA suppression on longer cycles.

Key Benefits

  • S-4 SARM — selective androgen receptor activation with partial profile
  • Effective at body-recomposition dosing
  • Distinct visual side-effect (yellow tinge) from ocular-pigment binding
  • Oral once or twice daily
  • Mild HPTA suppression — mini-PCT advisable
  • Each unit dosed at 5 mg — see Recommended Dosage below for protocol-specific intake

Quality Assurance

Vital Research is committed to delivering pharmaceutical-grade compounds with verified potency, purity, and sterility. Every batch undergoes rigorous third-party laboratory testing to ensure accurate dosing and absence of contaminants. With Vital Research, you receive a product backed by strict GMP manufacturing standards and complete traceability from raw material to finished product.

How It Works

Selective androgen receptor modulator with partial agonism profile. Tissue-selective effect on muscle and bone with minimal prostate/skin impact. Downstream anabolic signal milder than full-potency SARMs (ligandrol, RAD-140).

Pharmacokinetics

Plasma half-life approximately 4 hours — twice-daily dosing required. Oral bioavailability reasonable. Reconstituted oil or powder stable at room temperature.

Potential Side Effects

Signature visual disturbance: yellowing tint to vision, especially in low light. Resolves within 1–2 weeks of discontinuation. Mild HPTA suppression. HDL drops slightly.

Cycle & Stacking Guide

6–8 week cycles, 25–50 mg/day. Mini-PCT (Nolva 20 mg × 3 weeks) after 8-week runs. Often stacked with Ostarine or cardarine for cutting protocols.

Manufacturer Notes

Vital Research focuses on research compounds and support supplements with batch-specific quality control documentation.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “ACP-105 5 mg Vital Research”

Your email address will not be published. Required fields are marked *